# Cristina Saura

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/cristina-saura/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,913 |
| Field | HER2/EGFR in Cancer Research |
| h-index | 63 |
| i10-index | 169 |
| Last Known Institution | Hebron University |
| OpenAlex ID | https://openalex.org/A5082195410 |
| ORCID iD | https://orcid.org/0000-0001-8296-5065 |
| Works | 754 |

## Researcher papers

- [Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer](https://scholariq.org/papers/trastuzumab-deruxtecan-in-previously-treated-her2-low-advanced-breast-cancer/)
- [ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer](https://scholariq.org/papers/esmo-clinical-practice-guideline-for-the-diagnosis-staging-and-treatment-of/)
- [Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study](https://scholariq.org/papers/trastuzumab-duocarmazine-in-locally-advanced-and-metastatic-solid-tumours-and/)

## Researcher topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Researcher university

- [Hebron University](https://scholariq.org/institutions/hebron-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.